SEC Form 4 · accession 0001209191-15-040421
IDEXX LABORATORIES INC /DE · IDXX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel M Junius
Director
Period of report
May 6, 2015
Accepted (ET)
May 8, 2015 · 2:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000874716
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Deferred Stock UnitF1 | — | May 6, 2015 | A | 342 | A | — | — | Common Stock | 342 | 669 | D |
| Non-Qualified Stock Option (right to buy)F2 | $127.90 | May 6, 2015 | A | 3,861 | A | — | May 5, 2025 | Common Stock | 3,861 | 3,861 | D |
Explanation of responses
- F1Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The deferred stock units vest 100% on 05/04/2016 and are payable as common stock one year following the Director's resignation from the Board of Directors.
- F2Grant of options to buy shares of common stock that vest 100% on 05/04/2016.